Man And Machine Team Up for More Precise Surgeries at Overlook Medical...
March 30, 2017
As the surgeon uses the Mako system's robotic-arm, its tactile, auditory and visual feedback limits the bone preparation to the diseased areas and provides for real time adjustments and more optimal i
“Mako gives us the ability to better plan the patient’s surgery, make more precise cuts in the bone and make a much more accurate fit with an implant." - Jeff Leary, MD, Overlook Medical Center surgeon
Mammography Market Dynamics, Comprehensive Analysis, Business Growth, Prospects and Opportunities 2016-2022
October 30, 2017
Pune, India -- 10/30/2017 -- Market Research Future published a research report on "Global Mammography Market - Forecast To 2022" – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.Market Synopsis of Mammography Market:Market Scenario:Mammograms are low dose x-rays which can take X-ray picture of breast that can help detect various breast diseases like cancer. It cannot prevent breast cancer but mammography can detect cancer at an early stage which is helpful to start the treatment and cure of the same. Increase in number of breast cancer patients, growing awareness about health and increase in healthcare expenditure are the...
Mamava Stands Up for the Rights of Mothers (and Babies)
May 9, 2017
BURLINGTON, Vt., May 9, 2017 -- This Mother's Day, Mamava, maker of the world's first free standing lactation suite, is standing in solidarity with breastfeeding mothers and their babes with the release of a video announcing their new mobile locator app. The Mamava app provides a digital solution for the struggle endured by every breastfeeding mom: the lack of dignified space to express breastmilk. The new Mamava app supports moms on the go by locating Mamava lactation suites and over 1200 other Mamava-vetted public lactation...
Maltz Museum Spotlights Student Advocates For Equality With $100,000...
April 17, 2017
Cleveland, OH April 17, 2017
â€œI am more than the color of my skin.â€� â€œGender rules donâ€™t matter.â€� â€œSelf-hate is just as dangerous as any other.â€� "Where you're from shouldnâ€™t change how people treat you.â€� Nearly 3,300 Northeast Ohio 6-12th graders recently submitted these and other reflections on intolerance as part of the Maltz Museum of Jewish Heritage annual Stop the HateÂ® Youth Speak Out competition. Each student shared his or her experiences and ideas for effecting positive change in a 500-word essay. â€œItâ€™s...
Malta Welcomes Its First Domino's® Store
October 19, 2017
Anatron, a Domino's master franchisee in the region, opened the market in cooperation with a local partner, Famalco Group, a company based in Malta with experience in real estate, construction and motor vehicle dealerships. Together, their broad business experience makes them well-positioned to develop Domino's into a leading brand in Malta.
The new pizza theater store features local Maltese tile and an open concept design, allowing customers to watch their pizza being made each step of the way. The local franchisee is committed to serving delicious products, exceptional service and innovative ordering technology to the community.
"We've been steadily opening new stores around the world,...
Malpractice Claims Involving Electronic Health Records on the Rise
October 16, 2017
The study by the nation's largest physician-owned medical malpractice insurer reveals that claims in which EHRs are a factor grew from just two from 2007 through 2010 to 161 from 2011 through December 2016. Typically, the EHR is a contributing factor in a claim, rather than the primary cause, according to David B. Troxel, MD, study author and medical director at The Doctors Company.
It's the second study of its kind by The Doctors Company, which recognized early on that despite the potential of EHRs to advance the practice of good medicine and patient safety, there would be unanticipated consequences from this rapidly adopted new technology. The latest research compares 66 claims made from July 2014 through
Malong Technologies: Winner in G20 "Olympics of Startups"
July 7, 2017
Malong Technologies' breakthrough ProductAI® platform is a high performance 'intelligent eye' that enables machines to have human-like visual perception of products, including non-rigid objects such as fashion and fabrics, which have historically been infeasible for computers to recognize accurately without barcodes.
Malong Technologies beat startups from every nation at the G20, which represents the 20 major economies of the world. Judged by officials of the European Union and other international organizations, the competition, run by the "Get in the Ring" foundation, led participants through a series of six rounds held over two days, and included 'head-to-head' oratory matchups inside a replica boxing ring.
The three winning nations include China,...
Mallinckrodt plc Discusses Pipeline Transformation, Company Outlook at Investor Briefing
October 4, 2017
The event will highlight how Mallinckrodt's ongoing portfolio transformation has enhanced financial strength and broadened future opportunities, providing long-term value for patients and shareholders.
At the briefing, members of the company's management team and medical experts, both internal and external, will share insights on a number of topics, including:
Development pipeline highlights:
Updates on the company's broad spectrum of near- and longer-term developmental programs for inline and investigational assets, including clinical and health economic data
Aggregate net sales expectations for near-term development programs, the...
Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product
October 2, 2017
Under terms of the agreement, later today Mallinckrodt will pay $10 million upfront with cash on hand to reimburse NeuroproteXeon for certain product development costs, and gains exclusive rights to commercialize the therapy, if approved, in the U.S., Canada, Japan and Australia. Mallinckrodt will make additional payments of up to $25 million dependent on achievement of clinical, regulatory and sales milestones as well as a tiered, net-sales-based royalty. NeuroproteXeon...
Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin, its Proprietary Therapy in Late-Stage Development for Newborns at Risk for Severe Jaundice
September 25, 2017
"The addition of stannsoporfin further expands and diversifies Mallinckrodt's pediatric pipeline, and will add strength and breadth to our Specialty Brands business," said Mark Trudeau, Chief Executive Officer at Mallinckrodt. "There is an urgent need for therapies to treat thousands of infants at risk for serious illness or death due to severe jaundice, and Mallinckrodt is committed to bringing stannsoporfin to this population as quickly and efficiently as possible."
Mallinckrodt has made an upfront payment of $80 million, with additional...